Aubrai by Bio
AUBRAI
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
AUBRAI (Aubrai by Bio) is an onchain AI co-scientist for longevity research built on Base within the Bio Protocol and VitaDAO ecosystems, utilizing research data associated with Dr. Aubrey de Grey. The project benefits from identifiable, reputable ecosystem backers (Team & Governance: 6.0/10) and has maintained a clean security record with no exploits, hacks, or regulatory actions to date. However, several critical weaknesses constrain its overall evaluation. Active development (5.0/10) shows functional product milestones but lacks transparent engineering internals and public code commit metrics. Security & Audit History (4.5/10) reveals a complete absence of third-party smart contract audits or formal security ratings, relying instead on TEE infrastructure. Furthermore, Tokenomics (3.5/10) and Market & Use Case (3.5/10) highlight severe operational hurdles, including a ~95% drawdown from ATH, an undisclosed token allocation breakdown, negligible daily trading volume (~$263), and minimal standalone community governance (3.0/10). No qualifying red-flag cap events were triggered, and the final score reflects the exact weighted average across all six fully evaluated sections.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About Aubrai by Bio (AUBRAI)
AUBRAI (Aubrai by Bio) is an on-chain decentralized scientific AI agent for longevity research deployed on the Base network. Co-developed by VitaDAO and BIO Protocol, the project operates as an AI co-scientist trained on unpublished laboratory data from Dr. Aubrey de Grey. The agent runs within a Phala Cloud Trusted Execution Environment (TEE) utilizing ElizaOS v2, with research hypotheses minted on Base through Molecule's Proof of Invention framework. Launched in August 2025 via the BIO Protocol launchpad, the project integrates with VitaLabs IPT funding flows.
The AUBRAI token features a fixed maximum supply of 2,000,000 tokens, with approximately 1.43 million in circulation. The token model includes a burn-on-early-redemption mechanism from its Ignition Sale, where early redemption burns locked allocations. Token-specific governance is not implemented on-chain, as community coordination and project oversight are shared with VitaDAO and BIO Protocol rather than an independent decentralized autonomous organization.
Market and security evaluations highlight several risks. The token has experienced a price crash of approximately 95% from its all-time high, accompanied by low daily trading volume and liquidity. While no exploits, hacks, or regulatory actions have occurred, AUBRAI has not undergone a third-party smart contract security audit, and detailed token allocation distributions remain undisclosed.